Cystoid Macular Edema After Vitrectomy for Rhegmatogenous Retinal Detachment
NCT ID: NCT05069675
Last Updated: 2022-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2021-07-12
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Primary Vitrectomy for the Treatment of Retinal Detachment in Highly Myopic
NCT01480505
Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes
NCT01771939
Evolution of Aqueous Flare in Rhegmatogenous Retinal Detachments Treated With Gas or Silicone Oil Tamponade.
NCT05053698
Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye
NCT02201706
Vitreous Detachment and Glaucoma Progression
NCT04719871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
demographics, systemic, and preoperative, intraoperative and post-operative data will be collected The sample size was calculated to obtain approximately 200 patients with cystoid macular edema. Since cystoid macular edema has been detected in 13% of patients after retinal detachment gas vitrectomy, and assuming that this event can occur between 10% and 15% of cases, the study will include at least 2000 cases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vitrectomy
vitrectomy with gas tamponade
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* follow-up of 3 months or more;
* age \> 18 years ;
* no previous eye surgery, except cataract surgery performed at least 6 months after hospitalization for retinal detachment;
* anatomical success, i.e. retinal re-attachment, after a single gas vitrectomy;
* no other eye surgery during follow-up;
* availability of optical coherence tomography (OCT) imaging
Exclusion Criteria
* macular hole;
* recurrent retinal detachment;
* use of silicone oil is used as a tamponading agent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Catania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Longo
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eye Clinic, University of Bari
Bari, , Italy
Eye Clinic, Humanitas University
Bergamo, , Italy
Eye Clinic, Azienda Policlinico San Marco
Catania, , Italy
Eye Clinic, University of Palermo
Palermo, , Italy
Eye Clinic, University of Perugia
Perugia, , Italy
Eye Clinic University of Turin
Turin, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Francesco Boscia, MD
Role: primary
Mario Romano, MD, PhD
Role: primary
Marco Lupidi, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Chatziralli I, Theodossiadis G, Dimitriou E, Kazantzis D, Theodossiadis P. Macular Edema after Successful Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment: Factors Affecting Edema Development and Considerations for Treatment. Ocul Immunol Inflamm. 2021 Jan 2;29(1):187-192. doi: 10.1080/09273948.2019.1652330. Epub 2019 Oct 2.
Banker TP, Reilly GS, Jalaj S, Weichel ED. Epiretinal membrane and cystoid macular edema after retinal detachment repair with small-gauge pars plana vitrectomy. Eur J Ophthalmol. 2015 Nov-Dec;25(6):565-70. doi: 10.5301/ejo.5000609. Epub 2015 Apr 15.
Joseph DP, Ryan EH, Ryan CM, Forbes NJK, Wagley S, Yonekawa Y, Mittra RA, Parke DW, Emerson GG, Shah GK, Blinder KJ, Capone A, Williams GA, Eliott D, Gupta OP, Hsu J, Regillo CD. Primary Retinal Detachment Outcomes Study: Pseudophakic Retinal Detachment Outcomes: Primary Retinal Detachment Outcomes Study Report Number 3. Ophthalmology. 2020 Nov;127(11):1507-1514. doi: 10.1016/j.ophtha.2020.05.005. Epub 2020 May 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69/2021/PO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.